News
-
-
-
COMMUNIQUÉ DE PRESSE
Newron notes the publication of new preclinical research suggesting evenamide ameliorates schizophrenia-related dysfunction
Newron Pharmaceuticals notes new preclinical research indicating evenamide may improve schizophrenia-related dysfunction by targeting hippocampal pathology. Study shows potential for novel therapeutic strategy -
-
COMMUNIQUÉ DE PRESSE
Organic growth acceleration in Q2. Resilient profitability. Targeting to deliver FY25 guidance.
ARYZTA AG reports organic growth acceleration in Q2 with resilient profitability, aiming to achieve FY25 guidance. Learn more about the international bakery company based in Switzerland -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Northern Data Group has been informed of a potential exchange offer to its shareholders by Rumble Inc.
Northern Data Group informed of potential exchange offer by Rumble Inc. for its shareholders. Evaluation ongoing with key terms expected to include share exchange ratio and debt reduction -
-
-
COMMUNIQUÉ DE PRESSE
New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals
New to The Street will air Show #683 on Bloomberg, featuring BioVie Inc., FLOKI, PetVivo Holdings, Inc., and NRx Pharmaceuticals, Inc. with insights on healthcare, biotech, blockchain gaming, and sports partnerships -
